Výsledky vyhledávání - "Mary, Kujawa"

A New Psychosocial Tool for Gaining Patient Understanding and Acceptance of Long-acting Injectable Antipsychotic Therapy

Autor: Robert A, Lasser, Nina R, Schooler, Mary, Kujawa, John, Docherty, Peter, Weiden

Publikováno v: Psychiatry (Edgmont (Pa. : Township)). 6(4)

Nonadherence to antipsychotic medications in serious, persistent mental illness remains a significant clinical challenge. Long-acting therapy was developed to help improve adherence to schizophrenia therapy and provide an effective means for ameliora

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::505feaadcde366de0038c855262697b4
https://pubmed.ncbi.nlm.nih.gov/19724728

Zobrazit plný text záznamu

Adjunctive risperidone in the treatment of generalized anxiety disorder: a double-blind, prospective, placebo-controlled, randomized trial

Autor: Gahan J, Pandina, Carla M, Canuso, Ibrahim, Turkoz, Mary, Kujawa, Ramy A, Mahmoud

Publikováno v: Psychopharmacology bulletin. 40(3)

Residual symptoms despite treatment are common in generalized anxiety disorders (GAD). The Patient-Rated Troubling Symptoms for Anxiety (PaRTS-A) is a newly created and validated instrument that measures the symptoms most troublesome to each individu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d6d81b3d3982d6f38e4460951a17e023
https://pubmed.ncbi.nlm.nih.gov/18007568

Zobrazit plný text záznamu

Risperidone for treatment-refractory major depressive disorder: a randomized trial

Autor: Ramy A. Mahmoud, Georges M. Gharabawi-Garibaldi, Mary Kujawa, Gahan Pandina, Ibrahim Turkoz, Colette Kosik-Gonzalez, Carla M. Canuso

Publikováno v: Annals of internal medicine. 147(9)

BACKGROUND Major depressive disorder has high prevalence, morbidity, and mortality. Inadequate results with antidepressants have prompts addition of a nonstandard treatment (augmentation therapy). OBJECTIVE To assess whether augmentation therapy with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5ee6b3a8629d1fa43a7999478088747
https://pubmed.ncbi.nlm.nih.gov/18669679

Zobrazit plný text záznamu

Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval

Autor: Georges M. Gharabawi, George M. Simpson, Erik Mannaert, Cynthia A. Bossie, Mary Kujawa, Ramy A. Mahmoud, Young Zhu, Ineke Naessens, Robert A. Lasser, Natalie C Gearhart

Publikováno v: Annals of General Psychiatry, Vol 6, Iss 1, p 3 (2007)
Annals of General Psychiatry

Background Several clinical studies have established the efficacy, safety, and tolerability of long-acting risperidone administered once every 2 weeks in patients with schizophrenia or schizoaffective disorder. This report evaluates preliminary effic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b285cf0123ea36c2a55f2e8c02385385
http://www.annals-general-psychiatry.com/content/6/1/3

Zobrazit plný text záznamu

A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder

Autor: Cynthia A. Bossie, George M. Simpson, Mary Kujawa, Ibrahim Turkoz, Georges M. Gharabawi, Steven Rodriguez, Robert A. Lasser, Ramy A. Mahmoud

Publikováno v: The Journal of clinical psychiatry. 67(8)

Objective This study examined the effects of 2 doses of long-acting risperidone injection in patients with schizophrenia or schizoaffective disorder. Method This 52-week, prospective, randomized, double-blind, multicenter, international study include

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88cca8bce2a7ad7ccf2ff83fb21d5cb6
https://pubmed.ncbi.nlm.nih.gov/16965196

Zobrazit plný text záznamu

Evaluation of a treatment manual for risperidone long-acting injectable

Autor: Ibrahim Turkoz, Robert Jones, Robert A. Lasser, John P. Docherty, Mary Kujawa

Publikováno v: Community mental health journal. 43(3)

We evaluated the usefulness of a treatment manual to facilitate the use of long-acting injectable risperidone in community mental health centers (CMHCs) during an open-label observational study. Perceived clinical utility and clinician adherence to t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fadf640cf5de09d36cfec475849f73f
https://pubmed.ncbi.nlm.nih.gov/17345148

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání